UNILOCH: Unipolar Versus Bipolar Interlocking in Humeral Shaft Fractures in Adults

Sponsor
Centre Hospitalier Universitaire Dijon (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05877014
Collaborator
(none)
390
1
2
49
8

Study Details

Study Description

Brief Summary

Shaft fractures account for 20% of humeral fractures and 3% of all adult fractures in France, with an estimated incidence of 13 to 20/100,000 people. Men aged 21 to 30 years and women aged 60 to 80 years are particularly affected. Intramedullary nailing is among the standard treatments for humeral shaft fractures (when surgery is required). Once inserted, the nail is locked in order to limit stress on the fractured bone, as well as possible secondary rotational displacements or malunion. Bipolar interlocking (BI) is typically performed on both sides (proximal and distal) of the fracture site. This procedure is performed under radiological control, exposing the patient and care team to radiation (during the entire procedure). The objective of the treatment is to obtain consolidation of the fracture within 12 months, and to limit the occurrence of irreversible complications such as malunion or nonunion (2-10% at 12 months post-surgery). The "unipolar interlocking" (UI) technique has recently been introduced. In this technique, locking is performed only on the proximal side of the fracture site. By avoiding the distal approach, potential complications such as radial nerve damage, with the risk of irreversible paralysis (3.8-14.2% in studies of the BI technique in this indication) or the risk of infection on the distal side can be avoided. It also reduces operative time, and consequently the radiation received by patients and caregivers. However, the UI may be poorly positioned, resulting in malunion that requires revision surgery.

Despite the absence of recommendations due to the lack of existing data, several teams use the UI in routine care. In this context, a descriptive cohort of 121 patients operated on at the Dijon University Hospital5 showed similar rates of consolidation between the 2 techniques (93.8% for UI versus 95.2% for BI, p=0.64), functional scores, and complications, as well as a significant 29% decrease in operating time in the UI group (mean + SD: 63.1±21.3 min versus 88.0±30.1 min for VB, p<0.01). These encouraging results, although limited by the retrospective and observational nature of the data, justify a prospective randomized trial comparing these two techniques.

Condition or Disease Intervention/Treatment Phase
  • Other: questionnaires
  • Other: scanner
Phase 3

Study Design

Study Type:
Interventional
Anticipated Enrollment :
390 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Unipolar Versus Bipolar Interlocking in Humeral Shaft Fractures in Adults
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Oct 1, 2027
Anticipated Study Completion Date :
Oct 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Unipolar interlocking group

Other: questionnaires
EQ-5D-5L and SF-12

Other: scanner
CT scan at M9 and then at M12 if the humerus is not consolidated at M6

Active Comparator: Bipolar interlocking group

Other: questionnaires
EQ-5D-5L and SF-12

Other: scanner
CT scan at M9 and then at M12 if the humerus is not consolidated at M6

Outcome Measures

Primary Outcome Measures

  1. The proportion of patients with radiologically assessed bone healing at 12 months [Through study completion, an average of 12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient with written consent

  • Patient ≥18 years of age with a diagnosis of humeral shaft fracture (all types in the AO classification) requiring surgical treatment with intramedullary nailing

Exclusion Criteria:
  • Person not affiliated to national health insurance

  • Patient unable to attend all study visits

  • Patient with a pathologic fracture

  • Patient with a post-traumatic brachial plexus injury at the time of inclusion

  • Patient under court protection, guardianship or legal guardianship

  • Pregnant, parturient or breastfeeding woman

  • Patient admitted for revision surgery of a humerus fracture (insufficient healing or complication)

  • Patient with an acute or chronic, unstable or poorly controlled disease that may interfere with the evaluation of the study objective, as determined by the investigator.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chu Dijon Bourgogne Dijon France 21000

Sponsors and Collaborators

  • Centre Hospitalier Universitaire Dijon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire Dijon
ClinicalTrials.gov Identifier:
NCT05877014
Other Study ID Numbers:
  • MARTZ PHRCN 2021
First Posted:
May 26, 2023
Last Update Posted:
May 26, 2023
Last Verified:
May 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 26, 2023